Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00448422
Status:
COMPLETED
Last Update Posted:
2010-09-27
First Post:
2007-03-15
Brief Title:
Safety and Efficacy of Prulifloxacin vs Placebo in Treatment of Acute Gastroenteritis in Adult Travelers
Sponsor:
Optimer Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization:
Optimer Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization Data
Organization:
Optimer Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Class:
INDUSTRY
Study ID:
OPT-099-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Optimer Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
YK Shue
Old Organization:
Optimer Pharmaceuticals